About 25% of patients with one autoimmune disease are likely to develop another autoimmune condition. Dr Bonder, from Beth Israel Deaconess Medical Center in Boston, talks about the importance of screening patients with primary biliary...
About 25% of patients with one autoimmune disease are likely to develop another autoimmune condition. Dr Bonder, from Beth Israel Deaconess Medical Center in Boston, talks about the importance of screening patients with primary biliary...
Do you know whether ankylosing spondylitis affects patients with Crohn disease more often than those with ulcerative colitis, or vice versa? Find out by taking our pop quiz!
Do you know whether ankylosing spondylitis affects patients with Crohn disease more often than those with ulcerative colitis, or vice versa? Find out by taking our pop quiz!
The presence of drug-induced neutralizing antibodies against tumor necrosis factor-α inhibitors may be a reliable biomarker for assessing treatment efficacy in patients with inflammatory joint diseases, a recent study shows.
The presence of drug-induced neutralizing antibodies against tumor necrosis factor-α inhibitors may be a reliable biomarker for assessing treatment efficacy in patients with inflammatory joint diseases, a recent study shows.
